Memorial Sloan Kettering Cancer Center @ Commack (Limited Protocol Activities)

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Thyroid cancer2 trials
• Kidney cancer1 trial
• Pituitary tumours1 trial

Phase

• Phase 22 trials
• Early phase 11 trial
• Phase 1/21 trial

Status

• Active, not recruiting2 trials
• Completed2 trials

Lead sponsor

• Memorial Sloan Kettering Cancer Center4 trials

Running trials

• Active, not recruiting

  Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer

  NCT04238624· Phase 2· Memorial Sloan Kettering Cancer Center· Source

• Active, not recruiting

  Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid Cancer

  NCT03085056· Early phase 1· Memorial Sloan Kettering Cancer Center· Source

Closed trials

• Completed

  Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer

  NCT04337970· Phase 1/2· Memorial Sloan Kettering Cancer Center· Source

• Completed

  Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors

  NCT04042753· Phase 2· Memorial Sloan Kettering Cancer Center· Source